FOSUN INTL(00656) 新浪证券·2025-03-30 12:16Core Viewpoint - Fosun International Limited reported a total revenue of RMB 192.14 billion for the fiscal year 2024, demonstrating the effectiveness of its strategic transformation amid global economic fluctuations [1] Group 1: Core Business Performance - The four core subsidiaries, including Yuyuan, Fosun Pharma, Fosun Portugal Insurance, and Fosun Tourism, contributed a total revenue of RMB 134.65 billion, accounting for 70.1% of total revenue [2] - The group's total debt ratio remained stable at 52.0%, with cash reserves reaching RMB 106.34 billion [2] - The company completed asset disposals worth approximately RMB 30 billion, enhancing liquidity [2] - The net loss attributable to shareholders was RMB 4.35 billion, but after excluding one-time non-cash losses, a profit of RMB 750 million was achieved [2] Group 2: Globalization Strategy - Overseas business has become a new growth engine, with overseas sales of Fosun Pharma increasing by 30.8% year-on-year [3] - Four biological drugs entered the European and Latin American markets [3] - Fosun Portugal Insurance's international business proportion rose to 29.8%, with gross premium income reaching EUR 6.172 billion [3] - Hainan Mining accelerated its international expansion, acquiring oil field rights in Oman and initiating a zircon-titanium mine acquisition in Africa [3] - The Yuyuan Lantern Festival, after its debut in Paris, is set to launch in Vietnam and Thailand in 2025, marking a new chapter in cultural globalization [3] Group 3: Innovation and R&D Investment - The company invested RMB 6.9 billion in R&D, establishing over 20 global innovation centers [4] - Fosun Pharma received approvals for 16 indications for 7 innovative drugs, while Fosun Pharma's overseas subsidiary achieved a profit of RMB 820 million [4] - The application of VR/AR technology in the Yuyuan Lantern Festival created a cloud exhibition with millions of views, and Fosun Portugal Insurance's digital services covered nearly 20% of Portugal's population [4] Group 4: Strategic Ecosystem and Synergy - The "Insurance + Industry + Investment" flywheel strategy led to 14,000 signed health insurance policies, resulting in Fosun Health's first profit [5] - The light asset model flourished, with a RMB 5 billion biopharmaceutical industry fund established in the Greater Bay Area [5] - The Sanya AI-themed resort introduced digital concierge services [5] - The chairman of Fosun International, Guo Guangchang, emphasized the commitment to core industries and seizing opportunities in globalization and technological innovation [5] Group 5: ESG and Social Responsibility - The group maintained an MSCI ESG rating of AA, ranking among the top 5 in the global industry [6] - The "Rural Doctor Program" reached 16.34 million rural residents, and artemisinin-based treatments have helped 80 million malaria patients globally [6] - In 2024, the company committed to donating RMB 10 million worth of anti-malarial drugs to Africa, continuing its corporate social responsibility efforts [6]